Physician profile
John A Skiendzielewski
NPI 1942249586
$40,581.44
in general payments reported to CMS, 2019-2025
10 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Phlebology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,231 · 2020: $3,468 · 2021: $5,311 · 2022: $7,336 · 2023: $9,772 · 2024: $10K · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $19K · Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $19,200.00 |
| Food and Beverage | $1,036.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $37,661.33 | 2019-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Medtronic, INC. | $1,278.36 | 2021-2025 | Venaseal, Closurefast |
| Tactile Systems Technology INC | $696.50 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic Vascular, INC. | $468.62 | 2019 | |
| Biocompatibles, INC. | $216.13 | 2019 | |
| Boston Scientific Corporation | $147.21 | 2020-2021 | |
| Cashflow Solutions, LLC | $57.37 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Pfizer INC. | $26.95 | 2022 | |
| Resmed Corp | $15.23 | 2022 | |
| Nevro Corp. | $13.74 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Skiendzielewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.